UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2022 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
UNBX
Shares outstanding
17,209,280
Price per share
$0.06
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
27,018
Total reported value
$1,678
% of total 13F portfolios
0%
Share change
-2,555,518
Value change
-$981,499
Number of holders
5
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Alyeska Investment Group, L.P. 9.2% $1,641,215 1,578,091 Alyeska Investment Group, L.P. 31 Mar 2025

As of 30 Sep 2025, 5 institutional investors reported holding 27,018 shares of UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX). This represents 0.16% of the company’s total 17,209,280 outstanding shares.

Institutional Holders of UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 27,018 $1,678 -$981,499 $0.06 5
2025 Q2 2,582,539 $987,264 -$333,568 $0.38 34
2025 Q1 2,833,599 $2,947,154 -$356,278 $1.04 38
2024 Q4 3,165,970 $3,091,393 -$260,509 $0.98 34
2024 Q3 3,460,556 $5,086,884 +$29,142 $1.47 38
2024 Q2 3,450,626 $4,657,886 -$193,895 $1.35 38
2024 Q1 3,581,049 $5,872,222 -$1,431,137 $1.64 38
2023 Q4 4,312,965 $8,324,368 +$6,846,251 $1.93 39
2023 Q3 561,707 $1,348,977 -$170,548 $2.40 5
2023 Q2 2,679,132 $6,831,588 -$981,318 $2.55 38
2023 Q1 3,136,668 $5,110,114 -$2,780,020 $1.63 41
2022 Q4 4,365,661 $11,957,776 -$15,852,352 $2.74 49
2022 Q3 10,458,677 $4,135,114 +$4,135,154 $0.40 3